Filing Details
- Accession Number:
- 0001179110-16-025837
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-06-01 20:56:47
- Reporting Period:
- 2016-05-31
- Filing Date:
- 2016-06-01
- Accepted Time:
- 2016-06-01 20:56:47
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1384101 | Veracyte Inc. | VCYT | Services-Medical Laboratories (8071) | 205455398 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1588970 | H Bonnie Anderson | 6000 Shoreline Court, Suite 300 South San Francisco CA 94080 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-05-31 | 2,500 | $5.46 | 2,500 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2016-06-01 | 2,500 | $5.46 | 5,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 95,000 | Indirect | The Bonnie H. Anderson Living Trust |
Footnotes
- The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $5.42 to $5.50, inclusive. The reporting person undertakes to provide to Veracyte, Inc., any security holder of Veracyte, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
- The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $5.34 to $5.50, inclusive. The reporting person undertakes to provide to Veracyte, Inc., any security holder of Veracyte, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.